首页 > 最新文献

OphthaTherapy. Therapies in Ophthalmology最新文献

英文 中文
Contemporary possibilities in the diagnostics of anterior and posterior eye diseases with the use of new-generation OCT 新一代OCT诊断眼前后眼疾病的当代可能性
Pub Date : 2021-06-21 DOI: 10.24292/01.OT.300621.1
K. Paczwa, Justyna Mędrzycka, J. Gołębiewska, R. Różycki
Optical coherence tomography is a non-contact imaging method of the anterior and posterior segments of the eye that is based on laser scanning in spectral domain. This study presents diagnostic possibilities of the new generation Solix FullRange™ OCT&OCTA apparatus (Optovue) to examine meibomian glands, cornea, anterior chamber, as well iridocorneal angles and lens. In the posterior segment of the eye it allows for the precise evaluation of the vitreous body, choroid, retina, optic nerve and blood-flow measurements.
光学相干层析成像是一种基于光谱域激光扫描的眼球前后段非接触式成像方法。本研究展示了新一代Solix FullRange™OCT&OCTA仪器(Optovue)用于检查睑板腺、角膜、前房以及虹膜角膜角度和晶状体的诊断可能性。在眼后段,它允许精确评估玻璃体、脉络膜、视网膜、视神经和血流测量。
{"title":"Contemporary possibilities in the diagnostics of anterior and posterior eye diseases with the use of new-generation OCT","authors":"K. Paczwa, Justyna Mędrzycka, J. Gołębiewska, R. Różycki","doi":"10.24292/01.OT.300621.1","DOIUrl":"https://doi.org/10.24292/01.OT.300621.1","url":null,"abstract":"Optical coherence tomography is a non-contact imaging method of the anterior and posterior segments of the eye that is based on laser scanning in spectral domain. This study presents diagnostic possibilities of the new generation Solix FullRange™ OCT&OCTA apparatus (Optovue) to examine meibomian glands, cornea, anterior chamber, as well iridocorneal angles and lens. In the posterior segment of the eye it allows for the precise evaluation of the vitreous body, choroid, retina, optic nerve and blood-flow measurements.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124825706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Vision impairment as the first symptom of encephalomyelitis in a paediatric patient 视力障碍作为脑脊髓炎的第一症状在儿科患者
Pub Date : 2021-06-16 DOI: 10.24292/01.OT.250521
A. Świerczyńska, M. Woś
An 8-year-old boy was admitted to the Ophthalmology Department due to a vision impairment with an accompanying decrease in visual acuity and bilateral optic disc oedema. As a result of interdisciplinary diagnostics, acute disseminated encephalomyelitis, probably related to preceding infection, was diagnosed.
一名8岁男童因视力受损,并伴有视力下降及双侧视盘水肿而入院眼科。经跨学科诊断,诊断为急性播散性脑脊髓炎,可能与既往感染有关。
{"title":"Vision impairment as the first symptom of encephalomyelitis in a paediatric patient","authors":"A. Świerczyńska, M. Woś","doi":"10.24292/01.OT.250521","DOIUrl":"https://doi.org/10.24292/01.OT.250521","url":null,"abstract":"An 8-year-old boy was admitted to the Ophthalmology Department due to a vision impairment with an accompanying decrease in visual acuity and bilateral optic disc oedema. As a result of interdisciplinary diagnostics, acute disseminated encephalomyelitis, probably related to preceding infection, was diagnosed.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"60 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132437723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The application of the femtosecond laser in cataract surgery 飞秒激光在白内障手术中的应用
Pub Date : 2021-05-25 DOI: 10.24292/01.ot.300621.3
P. Kanclerz, K. Pluta
Introduction: Since the introduction, femtosecond laser-assisted cataract surgery (FLACS) was believed to revolutionize cataract surgery. However, the judgment of clinical benefits was found to be far more complex than initially might have been thought. The aim of this review was to analyze the benefits and drawbacks of FLACS compared to traditional phacoemulsification cataract surgery. Results: The benefits of FLACS include lower cumulated phacoemulsification time and endothelial cell loss, perfect centration of the capsulotomy, and the possibility to perform precise femtosecond-assisted arcuate keratotomy incisions. The major disadvantages of FLACS are: high cost of the laser and the disposables for surgery, FLACS-specific intraoperative capsular complications, as well as the risk of intraoperative miosis and the learning curve. Conclusions: FLACS seems to be beneficial in some groups of patients i.e., with low baseline endothelial cell count, or those planning to receive multifocal intraocular lenses. Nevertheless, having considered that the advantages of FLACS might not be clear in every routine case, it cannot be considered as cost-effective.
导语:自问世以来,飞秒激光辅助白内障手术(FLACS)被认为是白内障手术的革命。然而,临床效益的判断被发现比最初想象的要复杂得多。本综述的目的是分析FLACS与传统超声乳化白内障手术相比的优点和缺点。结果:FLACS的优点包括较短的累积超声乳化时间和内皮细胞损失,囊膜切开术的完美集中,以及可以进行精确的飞秒辅助弓形角膜切开术切口。FLACS的主要缺点是:激光和手术用一次性材料的高成本,FLACS特有的术中包膜并发症,以及术中缩小的风险和学习曲线。结论:FLACS似乎对一些患者组有益,即基线内皮细胞计数低或计划接受多焦人工晶状体的患者。然而,考虑到FLACS的优势在每个常规病例中可能并不明显,因此不能认为它具有成本效益。
{"title":"The application of the femtosecond laser in cataract surgery","authors":"P. Kanclerz, K. Pluta","doi":"10.24292/01.ot.300621.3","DOIUrl":"https://doi.org/10.24292/01.ot.300621.3","url":null,"abstract":"Introduction: Since the introduction, femtosecond laser-assisted cataract surgery (FLACS) was believed to revolutionize cataract surgery. However, the judgment of clinical benefits was found to be far more complex than initially might have been thought. The aim of this review was to analyze the benefits and drawbacks of FLACS compared to traditional phacoemulsification cataract surgery. \u0000Results: The benefits of FLACS include lower cumulated phacoemulsification time and endothelial cell loss, perfect centration of the capsulotomy, and the possibility to perform precise femtosecond-assisted arcuate keratotomy incisions. The major disadvantages of FLACS are: high cost of the laser and the disposables for surgery, FLACS-specific intraoperative capsular complications, as well as the risk of intraoperative miosis and the learning curve. \u0000Conclusions: FLACS seems to be beneficial in some groups of patients i.e., with low baseline endothelial cell count, or those planning to receive multifocal intraocular lenses. Nevertheless, having considered that the advantages of FLACS might not be clear in every routine case, it cannot be considered as cost-effective.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116082496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retained subretinal perfluorocarbon in multimodal image 多模态图像中残留的视网膜下全氟碳化合物
Pub Date : 2021-04-08 DOI: 10.24292/01.OT.100421
Elena Guzmán Almagro, R. Cobo Soriano, Irene Fuentes-Vega, A. Fernández Hortelano, J. González Martín-Moro
Introduction: Retained subretinal perfluoro-n-octane droplets occur in nearly 1% of the procedures. When subretinal cystoid cavities are registered, differential diagnosis including this condition is needed. Clinical case: A 77-year-old male presented three small bubbles of perfluoro-n-octane under the papillomacular bundle after vitrectomy due to a retina redetachment, evidenced by multimodal image. Conclusions: Multimodal image can help to diagnose this condition. There are several signs that can support this diagnosis. If visual acuity is threatened, removing the bubbles is mandatory, accepting risks.
导读:视网膜下残留的全氟辛烷液滴在近1%的手术中发生。当视网膜下囊样腔被记录时,需要鉴别诊断包括这种情况。临床病例:一名77岁男性,因视网膜再脱离玻璃体切除术后,在乳头状斑束下出现三个全氟辛烷小泡,多模态图像证实。结论:多模态图像有助于诊断本病。有几个迹象可以支持这种诊断。如果视力受到威胁,就必须去除气泡,接受风险。
{"title":"Retained subretinal perfluorocarbon in multimodal image","authors":"Elena Guzmán Almagro, R. Cobo Soriano, Irene Fuentes-Vega, A. Fernández Hortelano, J. González Martín-Moro","doi":"10.24292/01.OT.100421","DOIUrl":"https://doi.org/10.24292/01.OT.100421","url":null,"abstract":"Introduction: Retained subretinal perfluoro-n-octane droplets occur in nearly 1% of the procedures. When subretinal cystoid cavities are registered, differential diagnosis including this condition is needed. \u0000Clinical case: A 77-year-old male presented three small bubbles of perfluoro-n-octane under the papillomacular bundle after vitrectomy due to a retina redetachment, evidenced by multimodal image. \u0000Conclusions: Multimodal image can help to diagnose this condition. There are several signs that can support this diagnosis. If visual acuity is threatened, removing the bubbles is mandatory, accepting risks.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131842617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current classification of macular neovascularization in the course of AMD based on the Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data 基于新血管性年龄相关性黄斑变性数据报告共识命名法的AMD过程中黄斑新生血管的当前分类
Pub Date : 2021-03-31 DOI: 10.24292/01.ot.310321.k
A. Piotrowicz, K. Paczwa, J. Gołębiewska, R. Różycki
Despite the improvement of diagnostic and therapeutic techniques age-related macular degeneration is still one of the main causes of central vision impairment. Throughout the years, the classification of subretinal neovascularization in the course of age-related macular degeneration has changed due to the advancement of diagnostic and therapeutic techniques. In 2020 an expert panel reached consensus on a new nomenclature for neovascularization in the course of age-related macular degeneration introducing the concept of macular neovascularization, which refers to each neovascularization in macula, regardless of the location.
尽管诊断和治疗技术的进步,年龄相关性黄斑变性仍然是中央视力障碍的主要原因之一。多年来,由于诊断和治疗技术的进步,老年性黄斑变性过程中视网膜下新生血管的分类发生了变化。2020年,一个专家小组就老年性黄斑变性过程中新生血管的新命名达成共识,引入了黄斑新生血管的概念,它指的是黄斑中的每一个新生血管,无论其位置如何。
{"title":"Current classification of macular neovascularization in the course of AMD based on the Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data","authors":"A. Piotrowicz, K. Paczwa, J. Gołębiewska, R. Różycki","doi":"10.24292/01.ot.310321.k","DOIUrl":"https://doi.org/10.24292/01.ot.310321.k","url":null,"abstract":"Despite the improvement of diagnostic and therapeutic techniques age-related macular degeneration is still one of the main causes of central vision impairment. \u0000Throughout the years, the classification of subretinal neovascularization in the course of age-related macular degeneration has changed due to the advancement of diagnostic and therapeutic techniques. In 2020 an expert panel reached consensus on a new nomenclature for neovascularization in the course of age-related macular degeneration introducing the concept of macular neovascularization, which refers to each neovascularization in macula, regardless of the location.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"82 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117264414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zespół suchego oka w okresie pooperacyjnym po zabiegach laserowej korekcji wzroku
Pub Date : 2021-03-31 DOI: 10.24292/01.ot.310321.s
M. Tomczak, A. Chomicka, Andrzej Dmitriew
W pracy przedstawiono wyniki badań dotyczących wystąpienia, nasilenia i długości trwania zespołu suchego oka po wykonaniu laserowej korekcji wzroku i zastosowaniu kropli nawilżających bez konserwantów o określonym stężeniu procentowym hialuronianu sodu.Badania przeprowadzono na grupie 70 osób, u których wykonano zabieg laserowej korekcji wzroku.
{"title":"Zespół suchego oka w okresie pooperacyjnym po zabiegach laserowej korekcji wzroku","authors":"M. Tomczak, A. Chomicka, Andrzej Dmitriew","doi":"10.24292/01.ot.310321.s","DOIUrl":"https://doi.org/10.24292/01.ot.310321.s","url":null,"abstract":"W pracy przedstawiono wyniki badań dotyczących wystąpienia, nasilenia i długości trwania zespołu suchego oka po wykonaniu laserowej korekcji wzroku i zastosowaniu kropli nawilżających bez konserwantów o określonym stężeniu procentowym hialuronianu sodu.Badania przeprowadzono na grupie 70 osób, u których wykonano zabieg laserowej korekcji wzroku.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123883311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indywidualizacja wyboru metody korekcji wady wzroku
Pub Date : 2021-03-31 DOI: 10.24292/01.OT.310321.X
Joanna Wierzbowska, M. Smorawski, Dominik Uram
Właściwy wybór metody korekcji wady wzroku jest niezbędny do osiągnięcia optymalnych wyników i satysfakcji pacjenta. Wybór ten powinien być oparty na wynikach szczegółowego badania kwalifikacyjnego, oczekiwaniach pacjenta oraz doświadczeniu chirurga refrakcyjnego. W artykule przedstawiono główne kryteria wyboru najczęściej stosowanych metod rogówkowych i wewnątrzgałkowych w celu korekcji wszystkich wad refrakcji.
{"title":"Indywidualizacja wyboru metody korekcji wady wzroku","authors":"Joanna Wierzbowska, M. Smorawski, Dominik Uram","doi":"10.24292/01.OT.310321.X","DOIUrl":"https://doi.org/10.24292/01.OT.310321.X","url":null,"abstract":"Właściwy wybór metody korekcji wady wzroku jest niezbędny do osiągnięcia optymalnych wyników i satysfakcji pacjenta. Wybór ten powinien być oparty na wynikach szczegółowego badania kwalifikacyjnego, oczekiwaniach pacjenta oraz doświadczeniu chirurga refrakcyjnego. W artykule przedstawiono główne kryteria wyboru najczęściej stosowanych metod rogówkowych i wewnątrzgałkowych w celu korekcji wszystkich wad refrakcji.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"68 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125719931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD30-positive T-cell lymphoproliferation of the bulbar conjuntival mucosa showing spontaneous remission 球结膜粘膜cd30阳性t细胞增生表现自发缓解
Pub Date : 2021-03-19 DOI: 10.24292/01.ot.300321.5
P. Marticorena Álvarez, Guadalupe Garrido Ceca, M. Guijarro Rojas
Introduction: CD30-positive T-cell lymphoproliferative lesions represent a spectrum of heterogeneous disorders. Clinical case: An incision biopsy was performed in a 25-year-old man with a lump in the bulbar conjunctiva. Immunohistochemistry indicated membrane positivity for CD3 and CD30 in over 75%. PCR identified the monoclonal nature of the T-cells. The hematological study was normal. Following biopsy, the conjunctival tumor diminished until disappear. Conclusions: Mucosal CD30-positive T-cell lymphoproliferation could be ascribed to a reactive process but it is necessary to rule out a primary conjunctival tumor or the first manifestation of an anaplastic large cell lymphoma.
cd30阳性t细胞增生性病变是一种异质性疾病。临床病例:一个25岁的男人在球结膜肿块进行了切口活检。免疫组化示CD3和CD30膜阳性75%以上。PCR鉴定了t细胞的单克隆性质。血液学检查正常。活检后结膜肿瘤缩小直至消失。结论:粘膜cd30阳性t细胞淋巴增生可归因于反应性过程,但有必要排除原发性结膜肿瘤或间变性大细胞淋巴瘤的首发表现。
{"title":"CD30-positive T-cell lymphoproliferation of the bulbar conjuntival mucosa showing spontaneous remission","authors":"P. Marticorena Álvarez, Guadalupe Garrido Ceca, M. Guijarro Rojas","doi":"10.24292/01.ot.300321.5","DOIUrl":"https://doi.org/10.24292/01.ot.300321.5","url":null,"abstract":"Introduction: CD30-positive T-cell lymphoproliferative lesions represent a spectrum of heterogeneous disorders. \u0000Clinical case: An incision biopsy was performed in a 25-year-old man with a lump in the bulbar conjunctiva. Immunohistochemistry indicated membrane positivity for CD3 and CD30 in over 75%. PCR identified the monoclonal nature of the T-cells. The hematological study was normal. Following biopsy, the conjunctival tumor diminished until disappear. \u0000Conclusions: Mucosal CD30-positive T-cell lymphoproliferation could be ascribed to a reactive process but it is necessary to rule out a primary conjunctival tumor or the first manifestation of an anaplastic large cell lymphoma.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"86 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131477909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of visual process improvement in patients with homonymous hemianopia 异位性偏视患者视觉过程改善的疗效
Pub Date : 2021-03-18 DOI: 10.24292/01.OT.300321.4
Sławomir Nogaj, Katarzyna Dubas, A. Michalski
Homonymous hemianopia is a visual field defect following a stroke, tumor development, traumatic brain injury and other rare causes. Due to the damage to the visual system, lateral neglect occurs that induces difficulties with detecting objects on one side of the binocular visual field, which exposes patients to potential danger during daily activities, especially performed outside – in traffic. Different optical aids such as Fresnel prism have been developed to help those patients by increasing the perception of the affected hemifield. This prism correction can appear in various configurations, for instance: yoked prism, monocular and binocular sector prisms placed with a base to the affected side. The other option to deal with these patients is visual training based on stimulating the affected hemifield.
同质性偏视是一种由中风、肿瘤发展、创伤性脑损伤和其他罕见原因引起的视野缺陷。由于视觉系统的损伤,会发生侧向忽视,导致双眼视野一侧的物体检测困难,这使患者在日常活动中面临潜在危险,特别是在室外交通中进行。不同的光学辅助工具,如菲涅耳棱镜,已经被开发出来,通过增加受影响的半场的感知来帮助这些患者。这种棱镜矫正可以出现在不同的配置,例如:轭棱镜,单眼和双目扇形棱镜放置与一个基础的影响侧。治疗这些患者的另一种选择是基于刺激受影响的半脑区的视觉训练。
{"title":"Efficacy of visual process improvement in patients with homonymous hemianopia","authors":"Sławomir Nogaj, Katarzyna Dubas, A. Michalski","doi":"10.24292/01.OT.300321.4","DOIUrl":"https://doi.org/10.24292/01.OT.300321.4","url":null,"abstract":"Homonymous hemianopia is a visual field defect following a stroke, tumor development, traumatic brain injury and other rare causes. Due to the damage to the visual system, lateral neglect occurs that induces difficulties with detecting objects on one side of the binocular visual field, which exposes patients to potential danger during daily activities, especially performed outside – in traffic. Different optical aids such as Fresnel prism have been developed to help those patients by increasing the perception of the affected hemifield. This prism correction can appear in various configurations, for instance: yoked prism, monocular and binocular sector prisms placed with a base to the affected side. The other option to deal with these patients is visual training based on stimulating the affected hemifield.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"97 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125368301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idebenone – a new drug for patients with Leber's hereditary optic neuropathy 依地苯酮——一种治疗遗传性视神经病变的新药
Pub Date : 2021-03-17 DOI: 10.24292/01.OT.300321.3
D. Szumny, K. Czajor, M. Mulak
Leber's Hereditary Optic Neuropathy is a rare disease caused by a mutation in the mitochondrial DNA. It appears most often in young men, leading to profound, permanent loss of vision in a short time. There is no specific treatment for this condition.Idebenone is a medicine that administered to patients with Leber's hereditary optic neuropathy improves or stops the deterioration of vision. Increasing the number of people during therapy and the duration of treatment will allow in the future to answer the question, whether this drug is effective and safe in a larger group of patients.
利伯氏遗传性视神经病变是一种由线粒体DNA突变引起的罕见疾病。它最常见于年轻男性,可在短时间内导致严重的永久性视力丧失。这种情况没有特殊的治疗方法。依地苯酮是一种用于利伯氏遗传性视神经病变患者的药物,可以改善或阻止视力的恶化。增加接受治疗的人数和治疗的持续时间将使将来能够回答这个问题,即这种药物在更大的患者群体中是否有效和安全。
{"title":"Idebenone – a new drug for patients with Leber's hereditary optic neuropathy","authors":"D. Szumny, K. Czajor, M. Mulak","doi":"10.24292/01.OT.300321.3","DOIUrl":"https://doi.org/10.24292/01.OT.300321.3","url":null,"abstract":"Leber's Hereditary Optic Neuropathy is a rare disease caused by a mutation in the mitochondrial DNA. It appears most often in young men, leading to profound, permanent loss of vision in a short time. There is no specific treatment for this condition.Idebenone is a medicine that administered to patients with Leber's hereditary optic neuropathy improves or stops the deterioration of vision. Increasing the number of people during therapy and the duration of treatment will allow in the future to answer the question, whether this drug is effective and safe in a larger group of patients.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132894917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
OphthaTherapy. Therapies in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1